ST Pharm
ST Pharm
01
Who we are
02
Our record
03
Newsroom
04
Contact
En
Ko
ST Pharm
Science & Technology
Business Overview
CDMO
Small Molecule
Oligonucleotide
mRNA
CRO
AnaPath Research & Service
R&D
Virtual R&D
Global R&D
About
ST PHARM
Key Members
History
Global Approval
ST Pharm Family
CI
Public
PR (Public Relations)
News room
All
Media Focus
ST PHARM News
IR (Investor Relations)
Stock Information
IR Library
Disclosure Information
IR Materials
Notice
Careers
ESG
Overview
Environmental
Social
Governance
Sitemap
Contact
Linkedin
Public
Media Focus
PR (Public Relations)
News room
All
Media Focus
ST PHARM News
IR (Investor Relations)
Stock Information
IR Library
Disclosure Information
IR Materials
Notice
ST PHARM's Public Release
All
Media Focus
ST PHARM News
Media Focus
ST Pharm begins developing Korea's 1st LNP-based mRNA Covid-19 vaccine
Jun 1, 2021
Media Focus
Korean companies work on RNA Covid-19 treatments, vaccines
Apr 15, 2021
Media Focus
FDA Approves Zolgensma, first gene therapy for SMA
Jun 11, 2019
Media Focus
ST Pharm's Panel Discussion with TKS Publisher
Jun 10, 2019
3
of
2